The research team developing the microchip demonstrated its ability to produce high-contrast optical coherence tomography (OCT) images 0.6 mm deeper in human tissue.
Information on biomolecules' precise distribution in cells and tissues can help to produce a better understanding of disease and inflammation processes, and show new strategies for treating them.
A grant from the National Institutes of Health will support the pursuit of optical imaging technologies that can identify treatment-resistant tumors early in the treatment process.
Cytek Biosciences has received approval from the China National Medical Products Administration for its Northern Lights flow cytometer with 24+ color capability for clinical diagnostic use.
The graphene-based method allows localization of single molecules with nanometer resolution not only laterally, but also with similar accuracy along the third direction.
The method, called optical coherence refraction tomography, could improve medical images obtained in the OCT imaging industry for medical fields ranging from cardiology to oncology.
These nanoparticles can convert low-energy photons from near-infrared light into higher-energy green light that mammalian eyes can see.
The researchers integrated light manipulation devices called 3D plasmonic nanoarrays onto peelable films that can stick to any surface.
Optotek Medical specializes in developing optical and laser solutions for medical applications.
The fluorescence technique might be useful for quantifying the effects of tumor ablation therapy, where heat is used to destroy cancer cells, or in simply measuring for the presence of cancers.
The deep learning- and photonic time stretch-based approach could make it possible to extract cancer cells from blood immediately after they are detected.
The method combines the protein targeting specificity of commonly available antibodies with a DNA signal-amplification strategy.
The financing will further support MolecuLight's commercial expansion for the growing global demand for its fluorescence imaging device.
The tiny silica 'bottles' are filled with medicine and a temperature-sensitive material to kill malignant cells only in certain parts of the body.
Three studies demonstrate how a label-free 3D microscopy technique enables researchers to observe morphological and chemical alterations of host cells due to the malaria parasite infection.